FDA puts some peptides off limits FDA Announces Change in Status of 12 Peptides SSRP Institute BREAKING: The FDA just reversed their 2023 peptide ban. 12 peptides pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu 5. MOTS C 6. FDA Proposes Exclusion of Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List FDA posted on the topic LinkedIn Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA Moves to Reevaluate Several Peptides American Med Spa Association